Evidence map›Paper›PMID 39131377›Full record

ArticlebioRxiv : the preprint server for biology2025

Integrative, high-resolution analysis of single cell gene expression across experimental conditions with PARAFAC2-RISE.

Andrew Ramirez, Brian T Orcutt-Jahns, Sean Pascoe, Armaan Abraham, Breanna Remigio, Nathaniel Thomas, Aaron S Meyer

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Andrew RamirezDepartment of Bioengineering, University of California, Los Angeles (UCLA), CA, USA.
Brian T Orcutt-JahnsDepartment of Bioengineering, University of California, Los Angeles (UCLA), CA, USA.ORCID 0000-0002-1436-1224
Sean PascoeDepartment of Bioengineering, University of California, Los Angeles (UCLA), CA, USA.
Armaan AbrahamDepartment of Bioengineering, University of California, Los Angeles (UCLA), CA, USA.
Breanna RemigioComputational and Systems Biology, UCLA, CA, USA.
Nathaniel ThomasDepartment of Computer Science, UCLA, CA, USA.
Aaron S MeyerDepartment of Bioengineering, University of California, Los Angeles (UCLA), CA, USA.ORCID 0000-0003-4513-1840

Funding

Systems Epigenomics of Persistent Bloodstream InfectionU19AI172713 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI Monica Cappelletti · 2023 to 2026
$11.6M
NIAID NIH HHS U19 AI172713
6 · The paper itself

Abstract

Effective and scalable exploration and analysis tools are vital for the extraction of insights from large-scale single-cell data. However, current techniques for modeling single-cell studies performed across experimental conditions (e.g., samples, perturbations, or patients) require restrictive assumptions, lack flexibility, or do not adequately deconvolute condition-to-condition variation from cell-to-cell variation. Here, we report that Reduction and Insight in Single-cell Exploration (RISE), an adaptation of the tensor decomposition method PARAFAC2, enables the dimensionality reduction and analysis of single-cell data across conditions. We demonstrate the benefits of RISE across two distinct examples of single-cell RNA-sequencing experiments of peripheral immune cells: pharmacologic drug perturbations and systemic lupus erythematosus (SLE) patient samples. RISE enables straightforward associations of gene variation patterns with specific patients or perturbations, while connecting each coordinated change to single cells without requiring cell type annotations. The theoretical grounding of RISE suggests a unified framework for many single-cell data modeling tasks. Thus, RISE provides an intuitive universal dimensionality reduction approach for multi-sample single-cell studies across diverse biological contexts.

Indexed as

PARAFAC2scRNA-seqsingle-cell analysistensor decomposition

Identifiers

PMID39131377
PMCPMC11312543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.